Literature DB >> 14656752

A mathematical model of tissue-blood carbon dioxide exchange during hypoxia.

Guillermo Gutierrez1.   

Abstract

A two-compartment mass transport model of tissue CO(2) exchange is developed to examine the relative contributions of blood flow and cellular hypoxia (dysoxia) to increases in tissue and venous blood CO(2) concentration. The model assumes perfectly mixed homogeneous conditions, steady-state equilibrium, and CO(2) production occurring exclusively at the tissues. The behavior of the model is compared with published data derived from an isolated dog hindlimb preparation subjected to either reductions in blood flow (ischemic hypoxia) or decreases in arterial PO(2) (hypoxic hypoxia). The results of the model corroborate the experimental finding of greater venous and tissue CO(2) concentrations with ischemic hypoxia than with hypoxic hypoxia. The model also predicts increases in tissue CO(2) concentration under conditions of adequate O(2) supply if CO(2) transfer from tissue to blood becomes impaired. Consequently, from a theoretical perspective, it appears that increases in the tissue or venous blood CO(2) concentration are neither sensitive nor specific markers of tissue dysoxia. The results of the model support the notion that changes in tissue and venous blood CO(2) concentration during dysoxia reflect primarily alterations in vascular perfusion and not scarcity in cellular energy supply.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656752     DOI: 10.1164/rccm.200305-702OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  17 in total

1.  Gut mucosal permeability, β1 receptor blockers and gastric tonometry: the time is now!

Authors:  Guillermo Gutierrez; Guillermo Ballarino
Journal:  Intensive Care Med       Date:  2011-08-17       Impact factor: 17.440

2.  The venous-arterial partial pressure of carbon dioxide as a new monitoring of circulatory disorder: no so simple.

Authors:  J P Viale
Journal:  J Clin Monit Comput       Date:  2016-12       Impact factor: 2.502

3.  Venous-arterial CO2 to arterial-venous O2 difference ratio as a resuscitation target in shock states?

Authors:  Stephan M Jakob; A B Johan Groeneveld; Jean-Louis Teboul
Journal:  Intensive Care Med       Date:  2015-04-08       Impact factor: 17.440

Review 4.  Hemodynamic management of cardiovascular failure by using PCO(2) venous-arterial difference.

Authors:  Martin Dres; Xavier Monnet; Jean-Louis Teboul
Journal:  J Clin Monit Comput       Date:  2012-07-25       Impact factor: 2.502

Review 5.  Use of venous-to-arterial carbon dioxide tension difference to guide resuscitation therapy in septic shock.

Authors:  Jihad Mallat; Malcolm Lemyze; Laurent Tronchon; Benoît Vallet; Didier Thevenin
Journal:  World J Crit Care Med       Date:  2016-02-04

6.  Central venous-to-arterial carbon dioxide difference: an additional target for goal-directed therapy in septic shock?

Authors:  Fabrice Vallée; Benoit Vallet; Olivier Mathe; Jacqueline Parraguette; Arnaud Mari; Stein Silva; Kamran Samii; Olivier Fourcade; Michèle Genestal
Journal:  Intensive Care Med       Date:  2008-07-08       Impact factor: 17.440

7.  Ratio of venous-to-arterial PCO2 to arteriovenous oxygen content difference during regional ischemic or hypoxic hypoxia.

Authors:  Jihad Mallat; Benoit Vallet
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

8.  Increased blood flow prevents intramucosal acidosis in sheep endotoxemia: a controlled study.

Authors:  Arnaldo Dubin; Gastón Murias; Bernardo Maskin; Mario O Pozo; Juan P Sottile; Marcelo Barán; Vanina S Kanoore Edul; Héctor S Canales; Julio C Badie; Graciela Etcheverry; Elisa Estenssoro
Journal:  Crit Care       Date:  2005-01-11       Impact factor: 9.097

9.  Blood flow, not hypoxia, determines intramucosal PCO2.

Authors:  Guillermo Gutierrez
Journal:  Crit Care       Date:  2005-02-28       Impact factor: 9.097

10.  Central venous-to-arterial carbon dioxide difference as a prognostic tool in high-risk surgical patients.

Authors:  Emmanuel Robin; Emmanuel Futier; Oscar Pires; Maher Fleyfel; Benoit Tavernier; Gilles Lebuffe; Benoit Vallet
Journal:  Crit Care       Date:  2015-05-13       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.